<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02440386</url>
  </required_header>
  <id_info>
    <org_study_id>HRECREF:849/2014</org_study_id>
    <nct_id>NCT02440386</nct_id>
  </id_info>
  <brief_title>iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care</brief_title>
  <acronym>iLink</acronym>
  <official_title>iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cape Town</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cape Town</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The iLink Study examines whether a Conditional Economic Incentive (CEI) may be an effective&#xD;
      tool for improving linkage to HIV treatment and care following referral for antiretroviral&#xD;
      therapy (ART) services from a mobile health clinic in Cape Town, South Africa. The study&#xD;
      examines the feasibility and acceptability of using a R300 (approximately $25 as of April&#xD;
      2015) voucher - that is exchanged for cash upon initiation of ART within 3 months - to&#xD;
      increase the uptake of ART among men and women living in low-income areas. This pilot study&#xD;
      (n=64) includes a randomised control trial, follow-up telephone calls and medical record&#xD;
      reviews, and in-depth interviews.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The initiation of combination antiretroviral therapy (ART) remains a serious challenge&#xD;
      globally, and particularly in South Africa, the country with the largest population of people&#xD;
      living with HIV worldwide (UNAIDS 2012). South Africa has the largest ART programme globally,&#xD;
      yet only half of those needing ART in South Africa were receiving treatment in 2011 (Johnson&#xD;
      2012). Early initiation of ART improves treatment outcomes and reduces AIDS-related morbidity&#xD;
      and mortality. Recent studies have demonstrated a secondary benefit of ART in preventing HIV&#xD;
      transmission by reducing viral load and thus transmissibility (Cohen et al. 2011; Montaner et&#xD;
      al. 2010; Tanser et al. 2013). Despite the personal and public health benefits of ART, South&#xD;
      African studies have shown large loss to follow-up at each of the stages required for ART&#xD;
      initiation: (1) initial CD4 count testing and returning for results; (2) attending ART&#xD;
      readiness counselling; and (3) returning to initiate ART (April et al. 2009; Bassett et al.&#xD;
      2010; Kranzer et al. 2010; Larson et al. 2010; Losina et al. 2010).&#xD;
&#xD;
      Novel interventions are urgently needed to improve linkage to HIV treatment and care&#xD;
      post-diagnosis, as increased ART coverage will reduce AIDS-related morbidity and mortality,&#xD;
      and HIV incidence. Improving ART coverage is therefore a priority in many regions of the&#xD;
      world, and particularly in sub-Saharan Africa, where AIDS remains a key development&#xD;
      challenge. Interventions based on theories from the field of behavioural economics, a hybrid&#xD;
      of principles from psychology and economics (Bickel et al. 1995), have great potential to&#xD;
      help strengthen the contributions of psychology to improving ART outcomes. Conditional&#xD;
      economic incentives (CEIs), a financial incentive given upon completion of an outcome that&#xD;
      can be objectively measured (i.e. ART initiation), has the potential to leverage two&#xD;
      theoretical principles from behavioural economics to improve ART initiation. First, instead&#xD;
      of being completely rational and accurate, decision-making is viewed as inherently biased due&#xD;
      to a multitude of social-cognitive and affective factors that play a role in cost-benefit&#xD;
      analysis, such as emotions, personal beliefs, and contextual factors (Fiske &amp; Taylor 2008).&#xD;
      In other words, people's preferred outcomes are largely determined by salient contextual&#xD;
      needs (Operario et al. 2013). Second, people have a tendency to give greater value to rewards&#xD;
      in the present or near future than those in the more distant future (a phenomenon economists&#xD;
      term temporal discounting) and therefore decision-making favours immediate rewards and&#xD;
      heavily discounts future outcomes. This poses a challenge for ART initiation as the future&#xD;
      benefits of ART may be valued less than an individual's more immediate needs, especially for&#xD;
      individuals who currently perceive themselves to be relatively healthy.&#xD;
&#xD;
      A CEI may help overcome this challenge for ART initiation by increasing its immediate&#xD;
      benefits. A CEI may therefore help 'nudge' individuals to initiate ART by altering the&#xD;
      cost-benefit ratio so that the benefits of ART (i.e. the immediate financial reward and the&#xD;
      future health reward) outweigh the immediate costs of ART initiation, such as transport, time&#xD;
      off work, long waiting lines and the fear of stigma. The application of CEIs to address HIV&#xD;
      prevention and treatment problems is still in its infancy, but they have been successfully&#xD;
      employed to improve adherence to ART (Rosen et al. 2007; Sorensen et al. 2007; Javanbakht et&#xD;
      al. 2010), increase HIV testing uptake and the collection of HIV tests results (Thornton&#xD;
      2008), and reduce risky sexual behaviours (Baird et al. 2012). This evidence indicates that&#xD;
      small incentives-based interventions can 'nudge' individuals towards adopting healthier&#xD;
      behaviours.&#xD;
&#xD;
      The proposed research will make a significant contribution to our knowledge about demand&#xD;
      creation for HIV treatment and prevention services by examining whether CEIs may also be an&#xD;
      effective tool for improving linkage to HIV treatment and care following referral for ART&#xD;
      services. The proposed research will examine the feasibility and acceptability of using CEIs&#xD;
      to increase the uptake of ART among men and women who are referred for ART services. Our&#xD;
      long-term collaborative goal is to utilize the results from this pilot study to prepare a&#xD;
      grant application for a fully-powered RCT examining whether CEIs can increase ART initiation.&#xD;
&#xD;
      Objectives To examine the acceptability and feasibility of an incentive intervention aimed at&#xD;
      increasing uptake of ART among men and women who are referred for ART (CD4 &lt; 500 or WHO stage&#xD;
      4) by a mobile health clinic.&#xD;
&#xD;
      Acceptability&#xD;
&#xD;
        -  Did participants find the randomization process fair and acceptable?&#xD;
&#xD;
        -  Was the intervention an incentive that motivated or encouraged uptake of ART?&#xD;
&#xD;
        -  Was the incentive amount and type acceptable?&#xD;
&#xD;
        -  Were individuals in the control arm discouraged from ART initiation because they felt&#xD;
           that their linkage to care efforts were not rewarded?&#xD;
&#xD;
        -  Were there cases of patients who were unsatisfied or disappointed as a consequence of&#xD;
           the study (eg. they did not receive the incentive, yet they thought they should)?&#xD;
&#xD;
      Feasibility&#xD;
&#xD;
        -  Is it possible to recruit men and women into the study on the day of being referred for&#xD;
           ART?&#xD;
&#xD;
        -  Is it possible to track individuals and recruit individuals for in-depth interviews?&#xD;
&#xD;
        -  Is it possible to implement the study as planned:&#xD;
&#xD;
             -  Did the randomization process work?&#xD;
&#xD;
             -  Did participants understand the incentive system?&#xD;
&#xD;
             -  Did participants believe that they would actually receive the incentive?&#xD;
&#xD;
             -  Did the incentive delivery method work?&#xD;
&#xD;
        -  What is the potential for individuals to game the incentive system? Did any individuals&#xD;
           find a method of receiving the money without starting ART?&#xD;
&#xD;
      Potential Efficacy&#xD;
&#xD;
        -  Is ART initiation more likely among men and women who are offered the incentive compared&#xD;
           to men and women who are not offered the incentive?&#xD;
&#xD;
        -  Is early ART initiation more likely among men and women who are offered the incentive&#xD;
           compared to men and women who are not offered the incentive?&#xD;
&#xD;
        -  Does retention in care after ART initiation differ among men and women who are offered&#xD;
           the incentive compared to men and women not offered the incentive?&#xD;
&#xD;
        -  What is the potential for incentives to improve ART initiation given participants&#xD;
           behavioural intentions regarding ART initiation and barriers to ART initiation?&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ART initiation</measure>
    <time_frame>3 months</time_frame>
    <description>Commencement of antiretroviral therapy for HIV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to ART initiation</measure>
    <time_frame>1-52 weeks</time_frame>
    <description>Days between referral for ART and ART initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Linkage to Care: first visit to clinic</measure>
    <time_frame>3 months</time_frame>
    <description>Self-reported attendance at an HIV/ART clinic within 3 months of study enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to linkage to care</measure>
    <time_frame>1-52 weeks</time_frame>
    <description>Days between referral for ART and attendance at an HIV/ART clinic</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ART retention</measure>
    <time_frame>12 months</time_frame>
    <description>Indicator of whether the participant collected his/her ART 1 year after starting treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility - accrual percentage</measure>
    <time_frame>6 months</time_frame>
    <description>Number of people enrolled in study/number approached for enrollment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility - participant tracking</measure>
    <time_frame>3 and 6 months post enrolment</time_frame>
    <description>Number of participants contact at 3 and 6 months/number of participants enrolled</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability - adverse events</measure>
    <time_frame>6 months</time_frame>
    <description>Unexpected risks/harms of providing incentives as self-reported by participants</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control arm receives standard of care. Standard of care involves referral for ART services and follow-up calls (maximum of 6) to assess whether linkage to care has occurred.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Incentive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The incentive arm receives standard of care plus a R300 voucher. The R300 voucher can be exchanged for cash if the participant starts ART at any clinic of their choice within three months from study enrollment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Conditional economic incentive</intervention_name>
    <description>Individuals in the intervention arm will receive the standard of care. In addition, individuals in the intervention arm receive a voucher worth R300. They are told that they will get this money if they:&#xD;
Initiate ART at any clinic within 3 months from the time of their CD4 count test at the Tutu Tester; and&#xD;
send a text message to the study team to let us know they have started ART;&#xD;
Schedule a meeting with a member of the study team to show their clinic card and ARVs to confirm ART initiation.</description>
    <arm_group_label>Incentive</arm_group_label>
    <other_name>CEI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Referred for ART by the Tutu Tester Mobile Clinic (CD4 â‰¤ 500 or WHO stage 4)&#xD;
&#xD;
          -  Planning to live in the study area for the next 6 months&#xD;
&#xD;
          -  Willing and able to provide written informed consent for study participation&#xD;
&#xD;
          -  Willing to accept calls from the study staff&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participated in the study previously&#xD;
&#xD;
          -  Previously been on ART&#xD;
&#xD;
          -  Intoxicated at the time of enrolment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brendan Maughan-Brown, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cape Town</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Omar Galarraga, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tutu Tester Mobile Clinic, Desmond Tutu HIV Foundation</name>
      <address>
        <city>Cape Town</city>
        <state>Western Cape</state>
        <zip>7705</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <study_first_submitted>April 24, 2015</study_first_submitted>
  <study_first_submitted_qc>May 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <last_update_submitted>October 14, 2016</last_update_submitted>
  <last_update_submitted_qc>October 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cape Town</investigator_affiliation>
    <investigator_full_name>Brendan Maughan-Brown</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <pending_results>
    <submitted>December 7, 2018</submitted>
    <returned>March 26, 2019</returned>
    <submitted>November 20, 2020</submitted>
    <returned>December 15, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

